This inventor holds 43 USPTO granted patents and 1 published patent application and 5 EPO patents, primarily in Electrophotographic Imaging. Top assignees: Asahi Kogaku Kogyo Kabushiki Kaisha, Ricoh Company, Ltd., Ando Electric Company. Active years: 1991-2026.
Location History:
- Matsudo, JP (1991 - 1997)
- Chiba, JP (1992 - 2000)
- Saitama, JP (2016 - 2018)
- Tokyo, JP (1995 - 2019)
- Chiyoda-ku, JP (2020 - 2022)
Company Filing History:
28 out of 3,132 
6 out of 28,925 
4 out of 389 
Years Active: 1991-2026
Areas of Expertise:
Title: Innovations and Contributions of Tomoyuki Nishikawa
Introduction: Tomoyuki Nishikawa is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of oligonucleotide research. With an impressive portfolio of 34 patents to his name, Nishikawa has continually advanced the scientific understanding and application of oligonucleotides in various medical contexts.
Latest Patents: Among his latest inventions, Nishikawa has developed an oligonucleotide with improved affinity for AGO2. This innovative oligonucleotide features specific nucleotide and nucleoside residues designed to enhance its binding capabilities, potentially improving the knockdown activity of mRNAs linked to specific diseases. Moreover, he has introduced oligonucleotides that incorporate non-natural nucleotides at the 5' terminal, further pushing the boundaries of oligonucleotide functionality and application.
Career Highlights: Throughout his career, Tomoyuki Nishikawa has been associated with leading companies such as Asahi Kogaku Kogyo Kabushiki Kaisha and Ando Electric Company. His work at these organizations has been instrumental in developing novel methodologies and applications in nucleotide chemistry.
Collaborations: Nishikawa has collaborated with notable colleagues in his field, including Tsutomu Sato and Masahiro Kita. These partnerships have allowed for the fusion of diverse expertise, facilitating advancements in research and innovation within the realm of oligonucleotides.
Conclusion: Tomoyuki Nishikawa's contributions to the field of oligonucleotide research are noteworthy and impactful. His latest inventions demonstrate a commitment to increasing the efficacy of therapeutic applications, affirming his status as a leading inventor in the biotechnology sector. As he continues to innovate, the scientific community looks forward to his future discoveries and their potential applications.